-
Posted by
Two Blokes Jun 30 -
Filed in
Stock
-
8 views
I previously rated CCRN a sell, arguing that the FTC could block the merger because of concerns about competition in healthcare markets. The stock price now offers a 45% upside if the Aya merger closes, with the market pricing in only a 22% chance of the deal completing. Management continues to guide toward the deal completing in the second half of 2025.
